Skip to content

LIMNW

Liminatus Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.05
+11.67%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
4.38x
Price / sales
Price / cash flow
-0.33x

Enterprise value

Enterprise value
-$256.6K
EV / sales
EV / EBITDA
0.02x
EV / EBIT
0.06x
Market cap
$1.3M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026